PIEPER STEVEN (Chief Financial Officer) sold 0.4% of their position (5K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $42.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/1/2026ACC: 0001875714-26-000012
Officer· Chief Financial Officer
Since Oct 2021
-5K
Net shares
Net seller
$42.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$8.50
Trade value
$42.50K
% of position
0.4%
9/1/2026
1.36M→1.36M
Total
Net shares
−5K
Net value
-$42.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −5K | $8.50 | $42.50K | 0.4% | 1.36M | 1.36M |
| Total | −5K | -$42.50K | ||||||
Derivative Transactions0
No derivative transactions reported